NEWS
Genesis Capital backs in clinical research with Crux Biolabs deal
MELBOURNE: The biolabs deals are back! After a short hiatus, specialist healthcare private ... read more
Appen’s latest downgrade points to bigger problem
MELBOURNE: ASX-listed AI data firm Appen clearly has several serious problems, starting with ... read more
Roberts to decide final plans for Central Barangaroo as objections rise
SYDNEY: Planning Minister Anthony Roberts would need to override strenuous objections from the ... read more
